SPRUCE BIOSCIENCES, INC.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

SPRB$49.34+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	September 30,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$87,691	$48,906
Prepaid expenses	2,406	353
Other current assets	203	2,853
Total current assets	90,300	52,112
Right-of-use assets	450	666
Other assets	1,198	243
Total assets	$91,948	$53,021
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$2,732	$943
Accrued expenses and other current liabilities	11,978	9,143
Debt, current portion	4,000	—
Total current liabilities	18,710	10,086
Lease liabilities, net of current portion	155	419
Debt, net of current portion	3,822	—
Warrant liability	2,966	—
Total liabilities	25,653	10,505
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of September 30, 2026 and December 31, 2025	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 2,874,013 and 1,372,043 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	408,030	331,750
Accumulated deficit	(341,735)	(289,234)
Total stockholders’ equity	66,295	42,516
Total liabilities and stockholders’ equity	$91,948	$53,021

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.